Editas Medicine (EDIT) Enterprise Value Growth (3y) (2018 - 2025)
Editas Medicine (EDIT) Enterprise Value Growth (3y) (2018 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Editas Medicine | 245.95 Mn | 99.30 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 24.76% |
| Sep 30, 2025 | 26.64% |
| Jun 30, 2025 | 26.66% |
| Mar 31, 2025 | 23.23% |
| Dec 31, 2024 | 18.57% |
| Sep 30, 2024 | 21.96% |
| Jun 30, 2024 | 22.97% |
| Mar 31, 2024 | 22.05% |
| Dec 31, 2023 | 7.03% |
| Sep 30, 2023 | 10.96% |
| Jun 30, 2023 | 10.31% |
| Mar 31, 2023 | 8.45% |
| Dec 31, 2022 | 9.02% |
| Sep 30, 2022 | -8.05% |
| Jun 30, 2022 | -12.49% |
| Mar 31, 2022 | -12.60% |
| Dec 31, 2021 | -10.65% |
| Sep 30, 2021 | -18.24% |
| Jun 30, 2021 | -21.07% |
| Mar 31, 2021 | -20.34% |